Howard M. Sandler, MD

Ronald H. Bloom Family Chair in Cancer Therapeutics

Chair, Department of Radiation Oncology

Professor, Radiation Oncology

Cedars-Sinai Medical Center
8700 Beverly Blvd.
Los Angeles, CA 90048





8929 Wilshire Blvd.
Suite 100
Beverly Hills, CA 90211



Howard M. Sandler, MD

Ronald H. Bloom Family Chair in Cancer Therapeutics

Chair, Department of Radiation Oncology

Professor, Radiation Oncology

  • Radiation Oncology

Bladder Cancers

Brain Tumors

IMRT (Intensity-Modulated Radiation Therapy)

Prostate Cancers

Skin Cancers

Howard Sandler, MD, is principal investigator for a national Radiation Therapy Oncology Group study examining radiotherapy and chemotherapy for prostate cancer. He recently led a clinical trial grant funded by the National Institutes of Health to investigate novel radiation targeting strategies for prostate cancer. Dr. Sandler's studies also include evaluating the quality of life of prostate cancer patients following surgery and radiation therapy.

  • Medical School: University of Connecticut School of Medicine, 1985
  • Internship: St. Francis Hospital, 1986
  • Residency: Hospital of the University of Pennsylvania, 1989

View CV as a PDF

  • Program Chair, ASCO-ASTRO-SUO Genitourinary Cancer Symposium, 2010
  • Chairman, NRG Oncology/RTOG Genitourinary Cancer Committee, 1997
  • Zhao SG, Chang SL, Erho N, Yu M, Lehrer J, Alshalalfa M, Speers C, Cooperberg MR, Kim W, Ryan CJ, Den RB, Freedland SJ, Posadas E, Sandler H, et al. Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy. JAMA Oncol. 2017 May 11. [Epub ahead of print]
  • Lawton CAF, Lin X, Hanks GE, Lepor H, Grignon DJ, Brereton HD, Bedi M, Rosenthal SA, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Kim H, Parliament MB, Rabinovitch R, Roach M 3rd, Kwok Y, Dignam JJ, Sandler HM. Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202. Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):296-303. Epub 2017 Feb 12.
  • Shipley WU, Seiferheld W, Lukka HR, Major PP, Heney NM, Grignon DJ, Sartor O, Patel MP, Bahary JP, Zietman AL, Pisansky TM, Zeitzer KL, Lawton CA, Feng FY, Lovett RD, Balogh AG, Souhami L, Rosenthal SA, Kerlin KJ, Dignam JJ, Pugh SL, Sandler HM. Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer. N Engl J Med. 2017 Feb 2;376(5):417-428.
  • Lee WR, Dignam JJ, Amin MB, Bruner DW, Low D, Swanson GP, Shah AB, D'Souza DP, Michalski JM, Dayes IS, Seaward SA, Hall WA, Nguyen PL, Pisansky TM, Faria SL, Chen Y, Koontz BF, Paulus R, Sandler HM. Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer. J Clin Oncol. 2016 Jul 10;34(20):2325-32. Epub 2016 Apr 4.
  • Chen RC, Chang P, Vetter RJ, Lukka H, Stokes WA, Sanda MG, Watkins-Bruner D, Reeve BB, Sandler HM. Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials. J Natl Cancer Inst. 2014;106(7).
  • Jones CU, Hunt D, McGowan DG, Amin MB, Chetner MP, Bruner DW, Liebenhaut MH, Husain SM, Rotman M, Souhami L, Sandler HM, et al. Radiotherapy and short-term androgen deprivation for localized prostate cancer. N Engl J Med. 2011;365(2):107-118.
  • Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsy N, Saigal CS, Litwin MS, et al. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011;306(11):1205-1214.
  • Sandler HM, Liu PY, Dunn RL, Khan DC, Tropper SE, Sanda MG, Mantz CA. Reduction in patient-reported acute morbidity in prostate cancer patients treated with 81-Gy Intensity-modulated radiotherapy using reduced planning target volume margins and electromagnetic tracking: assessing the impact of margin reduction study. Urology. 2010;75(5):1004-1008.

Show moreShow less


Make an Appointment




Available 24 Hours A Day


Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to Howard M. Sandler, MD